Covalent modification of therapeutic compounds is a clinically proven strategy to devise
prodrugs with enhanced treatment efficacies. This prodrug strategy relies on the modified …

With an aging population that has been increasing in recent years, the need for the
development of therapeutic approaches for treatment of neurodegenerative disorders (ND) …

Conventional drug delivery systems face several issues in medical applications, such as
cyto/genotoxicity and off-targeting. These issues are particularly significant for cancer …

Nowadays, a malignant brain tumor is one of the most life-threatening diseases with poor
prognosis, high risk of recurrence, and low survival rate for patients because of the existence …

Brain cancer persists as a difficult‐to‐treat condition. In particular, metastatic brain cancer
and malignant primary brain tumors such as glioblastoma (GBM) are among the most deadly …

Phenolic compounds are prone to degradation from external deleterious conditions. Thus, a
carrier for its delivery can be useful in protecting them and ensuring their optimal release …

Abstract Carbon Nanotubes (CNTs) are known for effective adhesion, growth, and
differentiation of bone, muscle, and cardiac cells. CNTs can provide excellent mechanical …

Small molecule peptides and their derivatives are an emerging class of supramolecular
hydrogelators that have attracted rapidly growing interest in the fields of drug delivery and …

Monoclonal antibodies (mAbs) have received considerable attention over the past three
decades for the treatment of many diseases. With the significant titer improvement in cell …

The search of understanding the interaction of self-assembling nanostructures with proteins
in biological environments is leading to the rapid development of key applications, including …